| scholarly article | Q13442814 |
| P356 | DOI | 10.1378/CHEST.07-0058 |
| P698 | PubMed publication ID | 17908709 |
| P50 | author | George T O'Connor | Q47709105 |
| Robert E Walter | Q55908992 | ||
| Jemma B Wilk | Q67226687 | ||
| John Keaney | Q70457038 | ||
| Izabella Lipinska | Q114427802 | ||
| Emelia J. Benjamin | Q28754501 | ||
| Ramachandran S. Vasan | Q30348351 | ||
| Martin G Larson | Q37390385 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| chronic obstructive pulmonary disease | Q199804 | ||
| systemic inflammation | Q7663815 | ||
| P304 | page(s) | 19-25 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Systemic inflammation and COPD: the Framingham Heart Study | |
| P478 | volume | 133 |
| Q64963935 | A Strong Graded Relationship between Level of Obesity and COPD: Findings from a National Population-Based Study of Lifelong Nonsmokers. |
| Q36891689 | Adhesion molecules in subjects with COPD and healthy non-smokers: a cross sectional parallel group study |
| Q30415316 | Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts. |
| Q37125516 | Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis |
| Q38937853 | An ECLIPSE View of Alpha-1 Antitrypsin Deficiency |
| Q54549439 | An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. |
| Q47334748 | Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. |
| Q91839380 | Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease |
| Q33730864 | Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's Health and Aging Studies I and II |
| Q38580083 | Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q35421066 | Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study |
| Q37113883 | Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study |
| Q33650371 | Association of circulating adhesion molecules with lung function. The CARDIA study |
| Q36967440 | Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease |
| Q38644007 | Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma? |
| Q37994304 | Biomarkers in chronic obstructive pulmonary disease |
| Q37937720 | Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature |
| Q37012728 | Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease |
| Q36708107 | Bronchial responsiveness to dry air hyperventilation in smokers may predict decline in airway status using indirect methods |
| Q84784775 | C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation |
| Q35637295 | COPD association and repeatability of blood biomarkers in the ECLIPSE cohort |
| Q37233745 | COPD phenotype description using principal components analysis |
| Q38752544 | Can we predict the prognosis of COPD with a routine blood test? |
| Q35906553 | Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland |
| Q36446491 | Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk |
| Q38183116 | Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter |
| Q36575269 | Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations |
| Q37217701 | Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. |
| Q37356441 | Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury |
| Q59125694 | Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review |
| Q37417522 | Differential assessment and management of asthma vs chronic obstructive pulmonary disease. |
| Q92392945 | Does Poorer Pulmonary Function Accelerate Arterial Stiffening?: A Cohort Study With Repeated Measurements of Carotid-Femoral Pulse Wave Velocity |
| Q39677216 | E pluribus plurima: multidimensional indices and clinical phenotypes in COPD |
| Q35131487 | Effect of gene environment interactions on lung function and cardiovascular disease in COPD. |
| Q38089637 | Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms |
| Q42256739 | Effects of guideline-oriented pharmacotherapy in patients with newly diagnosed COPD: a prospective study |
| Q33741676 | Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function |
| Q36389310 | Emerging genetics of COPD. |
| Q40986838 | Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease |
| Q40082261 | FEV1 and FVC and systemic inflammation in a spinal cord injury cohort |
| Q33300819 | Framingham Heart Study genome-wide association: results for pulmonary function measures |
| Q23912027 | High hsCRP is associated with reduced lung function in structural firefighters |
| Q44956259 | High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease |
| Q33416183 | IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study |
| Q47654408 | Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients |
| Q43544835 | Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smoking |
| Q28388503 | Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration |
| Q43081658 | Interleukin-6 and statin therapy: potential role in the management of COPD. |
| Q97548808 | Low serum lymphocyte level is associated with poor exercise capacity and quality of life in chronic obstructive pulmonary disease |
| Q49045423 | Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease. |
| Q37553688 | Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research |
| Q38041635 | Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1. |
| Q84109110 | Peripheral blood neutrophil activity during Dermatophagoides pteronyssinus-induced late-phase airway inflammation in patients with allergic rhinitis and asthma |
| Q41854378 | Persistence of systemic inflammation in COPD in spite of smoking cessation |
| Q34280020 | Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype |
| Q45905529 | Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome? |
| Q38132823 | Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease. |
| Q36763590 | Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey |
| Q36221051 | Pulmonary Hypertension Secondary to COPD. |
| Q35744705 | Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study |
| Q90661409 | Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors |
| Q58605362 | Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study |
| Q93185924 | Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study |
| Q45837740 | Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis |
| Q38636712 | Small airway dysfunction in smokers with stable ischemic heart disease |
| Q37644907 | Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study. |
| Q37662217 | Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study. |
| Q42759714 | Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease |
| Q33831583 | Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome |
| Q41124329 | Systemic White Blood Cell Count as a Biomarker Associated with Severity of Chronic Obstructive Lung Disease. |
| Q38006928 | Systemic inflammation and comorbidities in chronic obstructive pulmonary disease |
| Q28390485 | Systemic inflammation and reduced pulmonary function in chronic spinal cord injury |
| Q33939195 | Systemic inflammation in chronic obstructive pulmonary disease: a population-based study |
| Q33631092 | Systemic inflammation in young adults is associated with abnormal lung function in middle age. |
| Q38056532 | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease |
| Q37734257 | Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease |
| Q38608866 | The Gut-Liver-Lung Axis. Modulation of the Innate Immune Response and Its Possible Role in Chronic Obstructive Pulmonary Disease |
| Q34065395 | The VICI-trial: high frequency oscillation versus conventional mechanical ventilation in newborns with congenital diaphragmatic hernia: an international multicentre randomized controlled trial |
| Q34022378 | The effect of a community-based, primary health care exercise program on inflammatory biomarkers and hormone levels |
| Q36158231 | The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease |
| Q37566305 | The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL). |
| Q54319662 | The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease. |
| Q24625481 | The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer |
| Q42634551 | The value of blood cytokines and chemokines in assessing COPD. |
| Q36750478 | Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease |
| Q37422824 | Update in chronic obstructive pulmonary disease 2008. |
| Q34656726 | Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities. |
| Q37242596 | Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study |
| Q37979248 | Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives |
| Q58698683 | Vitamin D status is associated with muscle strength and quality of life in patients with COPD: a seasonal prospective observation study |
| Q34378756 | gp130 at the nexus of inflammation, autoimmunity, and cancer |
Search more.